The Chemours Company (CC) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped CC stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: The Chemours Company exhibits a mix of promising growth initiatives and present challenges. While the short-term outlook reflects a degree of uncertainty due to regulatory and market risks, the medium-to-long-term potential for sustainable and innovative solutions positions Chemours as a compelling investment opportunity. Recent positive results and strong revenue growth estimates further support bullish sentiment, assuming continued execution of their strategic goals. The saved 1-year distribution is P10 $17.5, P50 $24.5, and P90 $30.
Last analyzed · Model: gpt-4o
The Chemours Company Forecast data
| Estimate | 1-year price | Meaning |
| P10 | $17.5 | Pessimistic plausible scenario |
| P50 | $24.5 | Median scenario |
| P90 | $30 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
Chemours has a mix of positive and negative factors influencing the short term. While the negative next EPS estimate weighs on sentiment, the massive revenue growth estimate and recent positive developments in eco-friendly chemicals provide significant bullish potential.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this CC analysis generated?
April 22, 2026.
Is this a guaranteed CC prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full CC stock analysis · CC sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.